AstraZenca and Serum Institute of India
After Pfizer, Serum Institute seeks indemnity over COVID-19 vaccine: Sources
NITI Aayog Member Dr VK Paul had said that the government is still examining the American pharma company's request for indemnity
Govt ready to allow other companies to make Covaxin
The government has now engaged five Public Sector Undertakings to help increase production of Covaxin
1 of 1